Cargando…

Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008

BACKGROUND: Clostridium difficile is the major cause of pseudomembranous colitis associated with antibiotic use, and the spread of the hypervirulent epidemic ribotype 027/NAP-1 strain across hospitals worldwide has re-focused attention on this nosocomial pathogen. The overall incidence and trend of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Li-Yang, Tan, Thean Yen, Koh, Tse Hsien, Kwa, Andrea L, Krishnan, Prabha, Tee, Nancy W, Jureen, Roland
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068971/
https://www.ncbi.nlm.nih.gov/pubmed/21429188
http://dx.doi.org/10.1186/1756-0500-4-77
_version_ 1782201294656634880
author Hsu, Li-Yang
Tan, Thean Yen
Koh, Tse Hsien
Kwa, Andrea L
Krishnan, Prabha
Tee, Nancy W
Jureen, Roland
author_facet Hsu, Li-Yang
Tan, Thean Yen
Koh, Tse Hsien
Kwa, Andrea L
Krishnan, Prabha
Tee, Nancy W
Jureen, Roland
author_sort Hsu, Li-Yang
collection PubMed
description BACKGROUND: Clostridium difficile is the major cause of pseudomembranous colitis associated with antibiotic use, and the spread of the hypervirulent epidemic ribotype 027/NAP-1 strain across hospitals worldwide has re-focused attention on this nosocomial pathogen. The overall incidence and trend of C. difficile-associated disease (CDAD) in Singapore is unknown, and a surveillance program to determine these via formal laboratory-based reporting was established. FINDINGS: Laboratory and pharmacy data were collated from one tertiary and two secondary hospitals on a quarterly basis between 2006 and 2008. All hospitals tested for C. difficile using Immunocard Toxins A&B (Meridian Bioscience Inc., Cincinnati, OH) during this period. Duplicate positive C. difficile results within a 14-day period were removed. The CDAD results were compared with trends in hospital-based prescription of major classes of antibiotics. Overall CDAD incidence-density decreased from 5.16 (95%CI: 4.73 - 5.62) cases per 10,000 inpatient-days in 2006 to 2.99 (95%CI: 2.67 to 3.33) cases per 10,000 inpatient-days in 2008 (p < 0.001), while overall rates for C. difficile testing increased significantly (p < 0.001) within the same period. These trends were mirrored at the individual hospital level. Evaluation of antibiotic prescription data at all hospitals showed increasing use of carbapenems and fluoroquinolones, while cephalosporin and clindamycin prescription remained stable. CONCLUSIONS: Our results demonstrate a real decline of CDAD rates in three large local hospitals. The cause is unclear and is not associated with improved infection control measures or reduction in antibiotic prescription. Lack of C. difficile stool cultures as part of routine testing precluded determination of the decline of a major clone as a potential explanation. For more accurate epidemiological trending of CDAD and early detection of epidemic clones, data collection will have to be expanded and resources set in place for reference laboratory culture and typing.
format Text
id pubmed-3068971
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30689712011-04-01 Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008 Hsu, Li-Yang Tan, Thean Yen Koh, Tse Hsien Kwa, Andrea L Krishnan, Prabha Tee, Nancy W Jureen, Roland BMC Res Notes Short Report BACKGROUND: Clostridium difficile is the major cause of pseudomembranous colitis associated with antibiotic use, and the spread of the hypervirulent epidemic ribotype 027/NAP-1 strain across hospitals worldwide has re-focused attention on this nosocomial pathogen. The overall incidence and trend of C. difficile-associated disease (CDAD) in Singapore is unknown, and a surveillance program to determine these via formal laboratory-based reporting was established. FINDINGS: Laboratory and pharmacy data were collated from one tertiary and two secondary hospitals on a quarterly basis between 2006 and 2008. All hospitals tested for C. difficile using Immunocard Toxins A&B (Meridian Bioscience Inc., Cincinnati, OH) during this period. Duplicate positive C. difficile results within a 14-day period were removed. The CDAD results were compared with trends in hospital-based prescription of major classes of antibiotics. Overall CDAD incidence-density decreased from 5.16 (95%CI: 4.73 - 5.62) cases per 10,000 inpatient-days in 2006 to 2.99 (95%CI: 2.67 to 3.33) cases per 10,000 inpatient-days in 2008 (p < 0.001), while overall rates for C. difficile testing increased significantly (p < 0.001) within the same period. These trends were mirrored at the individual hospital level. Evaluation of antibiotic prescription data at all hospitals showed increasing use of carbapenems and fluoroquinolones, while cephalosporin and clindamycin prescription remained stable. CONCLUSIONS: Our results demonstrate a real decline of CDAD rates in three large local hospitals. The cause is unclear and is not associated with improved infection control measures or reduction in antibiotic prescription. Lack of C. difficile stool cultures as part of routine testing precluded determination of the decline of a major clone as a potential explanation. For more accurate epidemiological trending of CDAD and early detection of epidemic clones, data collection will have to be expanded and resources set in place for reference laboratory culture and typing. BioMed Central 2011-03-23 /pmc/articles/PMC3068971/ /pubmed/21429188 http://dx.doi.org/10.1186/1756-0500-4-77 Text en Copyright ©2011 Hsu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Hsu, Li-Yang
Tan, Thean Yen
Koh, Tse Hsien
Kwa, Andrea L
Krishnan, Prabha
Tee, Nancy W
Jureen, Roland
Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008
title Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008
title_full Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008
title_fullStr Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008
title_full_unstemmed Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008
title_short Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008
title_sort decline in clostridium difficile-associated disease rates in singapore public hospitals, 2006 to 2008
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068971/
https://www.ncbi.nlm.nih.gov/pubmed/21429188
http://dx.doi.org/10.1186/1756-0500-4-77
work_keys_str_mv AT hsuliyang declineinclostridiumdifficileassociateddiseaseratesinsingaporepublichospitals2006to2008
AT tantheanyen declineinclostridiumdifficileassociateddiseaseratesinsingaporepublichospitals2006to2008
AT kohtsehsien declineinclostridiumdifficileassociateddiseaseratesinsingaporepublichospitals2006to2008
AT kwaandreal declineinclostridiumdifficileassociateddiseaseratesinsingaporepublichospitals2006to2008
AT krishnanprabha declineinclostridiumdifficileassociateddiseaseratesinsingaporepublichospitals2006to2008
AT teenancyw declineinclostridiumdifficileassociateddiseaseratesinsingaporepublichospitals2006to2008
AT jureenroland declineinclostridiumdifficileassociateddiseaseratesinsingaporepublichospitals2006to2008